Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of ascending multiple oral doses of SAM-531, an
investigational drug, in healthy young adult and elderly subjects.To assess the
pharmacokinetics (PK) and pharmacodynamics (PD) profiles of multiple oral doses of SAM-531 in
healthy young adult and elderly subjects.